Neurology® Podcast

Eligibility for Anti-Amyloid Treatment

10.12.2023 - By American Academy of NeurologyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPub.org/Podcast for associated article links.

More episodes from Neurology® Podcast